--- title: Buy Ziagen (Abacavir Sulfate) 300mg Pills Online description: Ziagen (Abacavir Sulfate) 300mg pills are part of HIV treatment regimens. Securely order from our online pharmacy for authentic medication. type: product language: en url: https://medsforsale.net/buy-ziagen-online-en availability: in_stock price_min: 302.99 price_max: 495.99 currency: USD offers: - name: 300mg x 30 pills price: 302.99 - name: 300mg x 40 pills price: 366.99 - name: 300mg x 50 pills price: 435.99 - name: 300mg x 60 pills price: 495.99 --- # Buy Ziagen (Abacavir Sulfate) 300mg Pills Online Ziagen, with Abacavir Sulfate, is a nucleoside reverse transcriptase inhibitor. It prevents HIV from multiplying in the body as part of combination therapy. Suitable for HIV-1 infected adults. Available in 300mg pills from our reliable online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **300mg** | 30 pills | **$302.99** | $10.10 | In Stock | | **300mg** | 40 pills | **$366.99** | $9.17 | In Stock | | **300mg** | 50 pills | **$435.99** | $8.72 | In Stock | | **300mg** | 60 pills | **$495.99** | $8.27 | In Stock | [Buy Now](https://medsforsale.net/buy-ziagen-online-en) ## Introduction Ziagen contains the active compound **Abacavir sulfate** and is supplied as a 300 mg oral tablet. It belongs to the nucleoside reverse-transcriptase inhibitor (NRTI) class and is prescribed primarily for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. By interfering with viral replication, Ziagen helps maintain immune function and reduces the risk of AIDS-defining illnesses. The medication is manufactured by ViiV Healthcare and is approved by major regulatory agencies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In addition to its approved use for HIV-1, research studies have explored several off-label applications, which are discussed later in this article. --- ## What is Ziagen? Ziagen is a brand-name product that delivers the generic antiviral agent **Abacavir sulfate**. It is available in a single strength of 300 mg per tablet and is taken orally. The drug was first approved by the FDA in 1998 and has since become a cornerstone of combination antiretroviral therapy (cART). Abacavir sulfate is also marketed under other brand names such as **Zalcitabine** (historical) and is a component of fixed-dose combinations like **Triumeq** (abacavir/lamivudine/dolutegravir). Ziagen is the stand-alone formulation of abacavir, offering a cost-effective option for patients who require this NRTI separate from other agents. --- ## How Ziagen Works Abacavir is a synthetic nucleoside analogue of guanosine. After oral absorption, it undergoes intracellular phosphorylation to the active triphosphate form, **abacavir-triphosphate**. This metabolite competes with the natural substrate deoxy-guanosine-triphosphate for incorporation into the viral DNA chain by reverse transcriptase. When abacavir-triphosphate is incorporated, it lacks a 3′-hydroxyl group, causing premature termination of DNA synthesis and halting viral replication. Key pharmacokinetic points: - **Onset:** Viral load reduction is typically observed within 1-2 weeks of initiating therapy. - **Distribution:** Abacavir penetrates peripheral blood mononuclear cells, the primary reservoir of HIV. - **Elimination:** The drug is cleared primarily by hepatic metabolism (glucuronidation) and renal excretion of inactive metabolites, with a plasma half-life of approximately 1.5 hours, allowing once-daily dosing. --- ## Conditions Treated with Ziagen ### HIV-1 Infection (Adults) Ziagen is approved as part of a combination regimen for adults with confirmed HIV-1 infection. It is indicated for: - **Initial therapy** in patients who are antiretroviral-naïve, when used with at least two other agents from different classes. - **Simplification** of existing regimens for patients who tolerate abacavir and have an undetectable viral load. **Rationale:** Abacavir’s potent inhibition of reverse transcriptase reduces viral replication, leading to increased CD4⁺ T-cell counts and decreased incidence of opportunistic infections. Clinical trials such as ACTG 5142 demonstrated non-inferiority of abacavir-containing regimens compared with other NRTIs when combined with protease inhibitors or integrase inhibitors. --- ## Off-Label and Investigational Uses of Ziagen - **Pre-exposure prophylaxis (PrEP) for high-risk HIV-negative individuals:** Small pilot studies have examined abacavir + lamivudine as a two-drug PrEP regimen, showing acceptable safety but limited efficacy data. Regulatory bodies have not approved this indication. - **Hepatitis B virus (HBV) co-infection:** Although abacavir displays modest activity against HBV polymerase, it is not recommended as primary HBV therapy. Some clinicians have added abacavir to nucleos(t)ide-analogue-based HBV regimens for HIV/HBV co-infected patients, but systematic evidence is lacking. - **Neuro-cognitive protection in HIV:** Observational research suggests that early initiation of abacavir may be associated with lower rates of HIV-associated neurocognitive disorders. These findings remain exploratory. *All off-label uses should be undertaken only under direct supervision of a qualified healthcare provider, as safety and efficacy have not been formally validated by the FDA, EMA, or comparable agencies.* --- ## Is Ziagen the Right Medication for You? Ziagen is appropriate for adults who: - Have confirmed HIV-1 infection and require an NRTI component of a cART regimen. - Possess the **HLA-B*57:01** allele negative status (testing is mandatory before starting abacavir due to hypersensitivity risk). - Do not have significant hepatic impairment (Child-Pugh class C) or severe renal dysfunction (creatinine clearance <30 mL/min) without dose adjustment. **Contraindications** include: - Documented hypersensitivity to abacavir or any tablet component. - Positive HLA-B*57:01 test. - Pregnancy or breastfeeding only after risk-benefit assessment; data are limited but no teratogenicity signal has been identified. Patients with active cardiovascular disease, uncontrolled liver disease, or concomitant use of certain antiretrovirals (e.g., didanosine) may require alternative therapy. --- ## Risks, Side Effects, and Interactions ### Common - **Headache** - often transient during the first weeks. - **Nausea or mild gastrointestinal upset** - may be reduced by taking the tablet with food. - **Fatigue** - usually mild and resolves with continued therapy. ### Rare - **Hypersensitivity reaction** - characterized by fever, rash, gastrointestinal symptoms, and respiratory involvement; occurs predominantly in HLA-B*57:01-positive individuals. - **Elevated liver enzymes** - isolated ALT/AST rise; monitor liver function tests quarterly. ### Serious - **Abacavir hypersensitivity syndrome (AHS):** A potentially life-threatening multi-system reaction that can progress to anaphylaxis. Immediate discontinuation and emergency care are required. - **Severe lactic acidosis or hepatic steatosis:** Rare metabolic complications associated with NRTI therapy, presenting with abdominal pain, rapid breathing, and jaundice. ### Drug-Drug Interactions - **Didanosine:** Co-administration increases didanosine toxicity; avoid concurrent use. - **Ritonavir-boosted protease inhibitors (e.g., lopinavir/ritonavir):** May increase abacavir plasma concentrations; monitor for toxicity. - **Cobicistat:** Similar effect as ritonavir; dose adjustment may be needed. - **Methadone:** Abacavir can lower methadone concentrations; monitor for withdrawal symptoms. ### Drug-Food Interactions - No significant food effects; however, taking Ziagen with a moderate-fat meal can improve tolerability of gastrointestinal side effects. **Patient safety tip:** Always inform your pharmacy of all prescription, over-the-counter, and herbal products you are using. --- ## Use: Dosing, Missed Dose, Overdose - **Standard dosing:** One 300 mg tablet taken orally once daily, preferably with the same meal each day to maintain steady plasma levels. - **Renal or hepatic impairment:** No routine dose reduction is required for mild to moderate dysfunction; severe impairment warrants specialist consultation. - **Missed dose:** If you remember the missed dose within 12 hours, take it immediately. If more than 12 hours have passed, skip the missed tablet and continue with the next scheduled dose. Do not double-dose. - **Overdose:** Symptoms may include nausea, vomiting, dizziness, or central nervous system depression. Seek immediate medical attention; supportive care (e.g., activated charcoal) is the mainstay of treatment. **Practical precautions:** - Avoid alcohol excess, as it may exacerbate hepatic strain. - Do not operate heavy machinery until you know how Ziagen affects you, especially during the initial treatment period. --- ## FAQ - **What should I know about storing Ziagen tablets?** Ziagen tablets should be kept in their original container at room temperature (15-30 °C), away from moisture, heat, and direct sunlight. Do not refrigerate or freeze. - **Can I travel internationally with Ziagen?** Yes, but carry a copy of your prescription (or a physician’s letter) and the original packaging. Some countries require proof of medical necessity for antiretrovirals. - **Does Ziagen interact with hormonal contraceptives?** No clinically significant interaction has been reported between abacavir and combined oral contraceptives; however, standard efficacy monitoring is advised. - **What are the inactive ingredients in Ziagen tablets?** Common excipients include lactose monohydrate, microcrystalline cellulose, and magnesium stearate. Patients with lactose intolerance should discuss alternatives with their provider. - **Is Ziagen safe for patients over 65 years old?** Clinical data support its use in older adults, but clinicians often assess comorbidities, renal function, and polypharmacy risk more closely in this population. - **How does Ziagen compare to tenofovir-based regimens?** Both abacavir and tenofovir are NRTIs, but they differ in metabolic pathways and toxicity profiles. Tenofovir carries a higher risk of renal tubular dysfunction and bone mineral loss, whereas abacavir’s primary safety concern is hypersensitivity. Choice depends on individual risk factors and resistance patterns. - **Can Ziagen be crushed or opened for patients with swallowing difficulties?** The tablet is not officially formulated for crushing; however, if necessary, a pharmacist may advise on a suitable alternative formulation (e.g., liquid abacavir). - **What laboratory monitoring is required while on Ziagen?** Baseline and periodic (every 3-6 months) measurements of CD4⁺ count, HIV viral load, liver enzymes, and complete blood count are recommended. HLA-B*57:01 testing must be performed before the first dose. - **Does Ziagen affect common laboratory tests or drug screenings?** Abacavir does not interfere with standard urine drug screens. It may cause a mild, transient elevation in serum bilirubin, which should be communicated to the laboratory. - **Why is HLA-B*57:01 testing mandatory before starting Ziagen?** The HLA-B*57:01 allele is strongly associated with abacavir hypersensitivity syndrome. Screening reduces the incidence of this potentially fatal reaction from ~5 % to <0.1 % in screened populations. --- ## Glossary **Nucleoside Reverse-Transcriptase Inhibitor (NRTI)** : A class of antiretroviral drugs that mimic natural nucleosides, become incorporated into viral DNA, and terminate chain elongation, thereby halting HIV replication. **HLA-B*57:01** : A specific human leukocyte antigen allele that predisposes carriers to a severe hypersensitivity reaction when exposed to abacavir. Testing for this allele is standard before initiating Ziagen. **Hypersensitivity Syndrome** : An immune-mediated reaction presenting with fever, rash, gastrointestinal symptoms, and potentially multi-organ involvement, requiring immediate drug discontinuation. **Pharmacokinetics** : The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body, influencing dosing schedules and potential interactions. --- ## Buying Ziagen from [our online pharmacy](https://medsforsale.net/buy-ziagen-online-en) Patients seeking a reliable source for Ziagen can obtain the medication from **[our online pharmacy](https://medsforsale.net/buy-ziagen-online-en)**. Our service offers the following advantages: - **Cost-effectiveness:** Prices are close to manufacturer-level rates, making generic abacavir an affordable option for long-term therapy. - **Verified quality:** All products are sourced from licensed, audited suppliers that meet international Good Manufacturing Practice (GMP) standards, ensuring potency and safety. - **Discreet, reliable delivery:** Orders are packaged in unmarked parcels and shipped via reputable carriers, typically arriving within 7 days with express service or 2-3 weeks using regular airmail. - **Global accessibility:** We operate as a pharmacy-broker service, connecting patients with overseas licensed pharmacies. This model expands access for individuals who face supply shortages, insurance limitations, or geographic barriers. By choosing **[our online pharmacy](https://medsforsale.net/buy-ziagen-online-en)**, you receive a secure, private, and economical channel to obtain Ziagen, supporting continuity of care without compromising confidentiality. --- ## Disclaimer The information presented about **Ziagen** is intended for general educational purposes and does not replace professional medical advice. Treatment decisions, including any off-label applications, must be made under the guidance of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://medsforsale.net/buy-ziagen-online-en) provides access to **Ziagen** for individuals who may encounter limited availability through conventional pharmacies or insurance programs, or who are seeking cost-effective generic alternatives. Always consult a qualified provider before initiating, adjusting, or discontinuing any medication.